Pekka Anttila

Publications

Research output per year 2013 2016 2019 2021 2022 2024

• 24 Article
• 2 Review Article
• 1 Meeting Abstract

Research output per year

Research output per year

Search results

• 2024

  Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group

  Partanen, A., Waage, A., Peceliunas, V., Schjesvold, F., Anttila, P., Säily, M., Uttervall, K., Putkonen, M., Carlson, K., Haukas, E., Sankelo, M., Szatkowski, D., Hansson, M., Marttila, A., Svensson, R., Axelsson, P., Lauri, B., Mikkola, M., Karlsson, C., Abelsson, J., & 9 othersAhlstrand, E., Sikiö, A., Klimkowska, M., Matuzeviciene, R., Fenstad, M. H., Ilveskero, S., Pelliniemi, T-T., Nahi, H. & Silvennoinen, R., Mar 2024, In: Cancers. 16, 5, 15 p., 1024.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

• Real-world treatment patterns and outcomes for patients with multiple myeloma in Denmark, Finland and Sweden: An analysis using linked Nordic registries

  Abildgaard, N., Anttila, P., Waage, A., Rubin, K. H., Ørstavik, S., Bent-Ennakhil, N., Gavini, F., Ma, Y., Freilich, J. & Hansson, M., Apr 2024, In: European Journal of Cancer. 201, 8 p., 113921.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File
• 2023

  Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy

  Luoma, S., Sergeev, P., Javarappa, K. K., Öhman, T. J., Varjosalo, M., Säily, M., Anttila, P., Sankelo, M., Partanen, A., Nihtinen, A., Heckman, C. A. & Silvennoinen, R., 4 May 2023, In: Cancers. 15, 9, 15 p., 2604.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

• Use of Linked Nordic Registries for Population Studies in Hematologic Cancers: The Case of Multiple Myeloma

  Abildgaard, N., Freilich, J., Anttila, P., Bent-Ennakhil, N., Ma, Y., Lassenius, M., Orstavik, S., Toppila, I., Waage, A., Turesson, I. & Hansson, M., 2023, In: Clinical Epidemiology. 15, p. 987-999 13 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File
• 2022

  A germline exome analysis reveals harmful POT1 variants in multiple myeloma patients and families

  Hakkarainen, M., Koski, J. R., Heckman, C. A., Anttila, P., Silvennoinen, R., Lievonen, J., Kilpivaara, O. & Wartiovaara-Kautto, U., Nov 2022, In: eJHaem. 3, 4, p. 1352-1357 6 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005-2016

  Toppila, I., Kysenius, K., Miettinen, T., Lassenius, M. I., Lievonen, J. & Anttila, P., Nov 2022, In: Annals of Hematology. 101, 11, p. 2485-2495 11 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File
• 2021

  Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen

  Miettinen, J., Kumari, R., Traustadottir, G. A., Huppunen, M-E. A., Sergeev, P., Majumder, M. M., Schepsky, A., Gudjonsson, T., Lievonen, J., Bazou, D., Dowling, P., O'Gorman, P., Slipicevic, A., Anttila, P., Silvennoinen, R., Nupponen, N. N., Lehmann, F. & Heckman, C., Apr 2021, In: Cancers. 13, 7, 21 p., 1527.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• Characteristics and survival trends in Finnish multiple myeloma patients-a nationwide real-world evidence study

  Toppila, I., Miettinen, T., Lassenius, M. I., Lievonen, J., Bauer, M. & Anttila, P., Jul 2021, In: Annals of Hematology. 100, 7, p. 1779-1787 9 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

• Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma

  Dimopoulos, M., Bringhen, S., Anttila, P., Capra, M., Cavo, M., Cole, C., Gasparetto, C., Hungria, V., Jenner, M., Vorobyev, V., Ruiz, E. Y., Yin, J. Y., Saleem, R., Hellet, M., Mace, S., Paiva, B. & Vij, R., 4 Mar 2021, In: Blood. 137, 9, p. 1154-1165 12 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients

  Tierney, C., Bazou, D., Majumder, M. M., Anttila, P., Silvennoinen, R., Heckman, C. A., Dowling, P. & O'Gorman, P., 18 Jun 2021, In: Scientific Reports. 11, 15 p., 12866.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• Prognostic significance of esterase gene expression in multiple myeloma

  Kumari, R., Majumder, M. M., Lievonen, J., Silvennoinen, R., Anttila, P., Nupponen, N. N., Lehmann, F. & Heckman, C. A., 12 Apr 2021, In: British Journal of Cancer. 124, 8, p. 1428-1436 9 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma

  Liu, M., Wang, Y., Miettinen, J. J., Kumari, R., Majumder, M. M., Tierney, C., Bazou, D., Parsons, A., Suvela, M., Lievonen, J., Silvennoinen, R., Anttila, P., Dowling, P., O’Gorman, P., Tang, J. & Heckman, C. A., 16 Aug 2021, In: Frontiers in Cell and Developmental Biology. 9, 14 p., 723016.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File
• 2020

  Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma

  Weisel, K., Dimopoulos, M., Moreau, P., Yagci, M., Larocca, A., Kanate, A. S., Vural, F., Cascavilla, N., Basu, S., Johnson, P., Byeff, P., Hus, M., Rodriguez-Otero, P., Muelduer, E., Anttila, P., Hayden, P. J., Krauth, M-T., Lucio, P., Ben-Yehuda, D., Mendeleeva, L., & 6 othersGuo, S., Yu, X., Grote, L., Biyukov, T., Dhanasiri, S. & Richardson, P., 2 Jul 2020, In: Leukemia & lymphoma. 61, 8, p. 1850-1859 10 p.

  Research output: Contribution to journal › Article › Scientific › peer-review
• 2019

  RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group

  Luoma, S., Anttila, P., Säily, M., Lundan, T., Heiskanen, J., Siitonen, T., Kakko, S., Putkonen, M., Ollikainen, H., Terävä, V., Sankelo, M., Partanen, A., Launonen, K., Räsänen, A., Sikiö, A., Suominen, M., Bazia, P., Kananen, K., Lievonen, J., Selander, T., & 7 othersPelliniemi, T-T., Ilveskero, S., Huotari, V., Mäntymaa, P., Tienhaara, A., Jantunen, E. & Silvennoinen, R., Dec 2019, In: Annals of Hematology. 98, 12, p. 2781-2792 12 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access
• 2018

  Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013

  Remes, K., Anttila, P., Silvennoinen, R., Putkonen, M., Ollikainen, H., Terävä, V., Sinisalo, M., Kananen, K., Schain, F., Castren-Kortegangas, P., Järvinen, T. M., Pisini, M., Wahl, F., Dixon, T. & Leval, A., 5 Dec 2018, In: PLoS One. 13, 12, 13 p., 0208507.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File
• 2017

  Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis

  Moreau, P., Dimopoulos, M. A., Richardson, P. G., Siegel, D. S., Cavo, M., Corradini, P., Weisel, K., Delforge, M., O'Gorman, P., Song, K., Chen, C., Bahlis, N., Oriol, A., Hansson, M., Kaiser, M., Anttila, P., Raymakers, R., Joao, C., Cook, G., Sternas, L., & 7 othersBiyukov, T., Slaughter, A., Hong, K., Herring, J., Yu, X., Zaki, M. & San-Miguel, J., Sept 2017, In: European Journal of Haematology. 99, 3, p. 199-206 8 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

• Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing

  Majumder, M. M., Silvennoinen, R., Anttila, P., Tamborero, D., Eldfors, S., Yadav, B., Karjalainen, R., Kuusanmaki, H., Lievonen, J., Parsons, A., Suvela, M., Jantunen, E., Porkka, K. & Heckman, C. A., 22 Aug 2017, In: Oncotarget. 8, 34, p. 56338-56350 13 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File
• 2016

  A randomized phase II study of stem cell mobilization with cyclophosphamide plus G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma

  Silvennoinen, R., Anttila, P., Saily, M., Lundan, T., Heiskanen, J., Siitonen, T. M., Kakko, S., Putkonen, M., Ollikainen, H., Terava, V., Kutila, A., Launonen, K., Rasanen, A., Sikio, A., Suominen, M., Bazia, P., Kananen, K., Selander, T., Kuittinen, T., Remes, K., & 1 othersJantunen, E., Mar 2016, In: Bone Marrow Transplantation. 51, 3, p. 372-376 5 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• Cost analysis of a randomized stem cell mobilization study in multiple myeloma

  Varmavuo, V., Silvennoinen, R., Anttila, P., Saily, M., Sankelo, M., Putkonen, M., Ahonen, J., Mahlamaki, E., Mantymaa, P., Savolainen, E-R., Remes, K. & Jantunen, E., Oct 2016, In: Annals of Hematology. 95, 10, p. 1653-1659 7 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma

  Dimopoulos, M. A., Palumbo, A., Corradini, P., Cavo, M., Delforge, M., Di Raimondo, F., Weisel, K. C., Oriol, A., Hansson, M., Vacca, A., Jesus Blanchard, M., Goldschmidt, H., Doyen, C., Kaiser, M., Petrini, M., Anttila, P., Cafro, A. M., Raymakers, R., San-Miguel, J., de Arriba, F., & 11 othersKnop, S., Roellig, C., Ocio, E. M., Morgan, G., Miller, N., Simcock, M., Peluso, T., Herring, J., Sternas, L., Zaki, M. H. & Moreau, P., 28 Jul 2016, In: Blood. 128, 4, p. 497-503 7 p.

  Research output: Contribution to journal › Article › Scientific › peer-review
• 2015

  Perinnöllinen makrotrombosytopenia ja kuulovika

  Ryhänen, S. J. & Anttila, P., 2015, In: Duodecim. 131, 9, p. 871-874 4 p.

  Research output: Contribution to journal › Article › Scientific › peer-review
• 2014

  Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma

  Silvennoinen, R., Lundan, T., Kairisto, V., Pelliniemi, T-T., Putkonen, M., Anttila, P., Huotari, V., Mantymaa, P., Siitonen, S., Uotila, L., Penttila, T-L., Juvonen, V., Selander, T. & Remes, K., Oct 2014, In: Blood cancer journal. 4, 7 p., 250.

  Research output: Contribution to journal › Article › Scientific › peer-review

• Genetic variation in schlafen genes in a patient with a recapitulation of the murine Elektra phenotype

  Recher, M., Karjalainen-Lindsberg, M-L., Lindlof, M., Söderlund-Venermo, M., Lanzi, G., Vaisanen, E., Kumar, A., Sadeghi, M., Berger, C. T., Alitalo, T., Anttila, P., Kolehmainen, M., Franssila, R., Chen, T., Siitonen, S., Delmonte, O. M., Walter, J. E., Pessach, I., Hess, C., Simpson, M. A., & 5 othersNavarini, A. A., Giliani, S., Hedman, K., Seppanen, M. & Notarangelo, L. D., May 2014, In: Journal of Allergy and Clinical Immunology. 133, 5, p. 1462-U382 9 p.

  Research output: Contribution to journal › Article › Scientific › peer-review
• 2013

  Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients

  Silvennoinen, R., Kairisto, V., Pelliniemi, T-T., Putkonen, M., Anttila, P., Saily, M., Sikio, A., Opas, J., Penttila, K., Kuittinen, T., Honkanen, T., Lundan, T., Juvonen, V., Luukkaala, T. & Remes, K., Feb 2013, In: British Journal of Haematology. 160, 4, p. 561-564 4 p.

  Research output: Contribution to journal › Article › Scientific